Acne vulgaris is a chronic inflammatory dermatosis which is notable for open and/or closed comedones (blackheads and whiteheads) and inflammatory lesions including papules, pustules or nodules.
Mild acne has <20 comedones or <15 inflammatory lesions or <30 total lesion count.
Moderate acne has 20-100 comedones or 15-20 inflammatory lesions or 30-125 total lesion count.
Severe papules/pustules or nodulocystic acne is the acne resistant to topical treatment or if scarring/nodular lesions are present.

Acne Vulgaris References

  1. Bershad SV. The modern age of acne therapy: a review of current treatment options. Mount Sinai J Med. 2001 Sep/Oct;68(4 & 5):279-286. PMID: 11514915
  2. Del Rosso JQ, Kim G. Optimizing use of oral antibiotics in acne vulgaris. Dermatol Clin. 2009 Jan;27(1):33-42. doi: 10.1016/j.det.2008.07.006. PMID: 18984366
  3. Clarke SB, Nelson AM, George RE, et al. Pharmacologic modulation of sebaceous gland activity: mechanisms and clinical applications. Dermatol Clin. 2007 Apr;25(2):137-146. PMID: 17430751
  4. Dawson AL, Dellavalle RP. Acne vulgaris. BMJ. 2013 May;346:d2634. doi: 10.1136/bmj.f2634. Accessed 26 Jul 2013. PMID: 23657180
  5. Feldman S, Careccia RE, Barham KL,et al. Diagnosis and treatment of acne. Am Fam Physician. 2004 May;69(9):2123-2130. PMID: 15152959
  6. Johnson BA, Nunley JR. Use of systemic agents in the treatment of acne vulgaris. Am Fam Physician. 2000 Oct;62(8):1823-1830,1835-1836. PMID: 11057839
  7. Liao DC. Management of Acne. J Fam Pract. 2003 Jan;52(1):43-51. PMID: 12540312
  8. Nestor MS. The use of photodynamic therapy for treatment of acne vulgaris. Dermatol Clin. 2007 Jan;25(1):47-57. PMID: 17126741
  9. Lehmann HP, Robinson KA, Andrews JS, et al. Acne therapy: a methodologic review. J Am Acad Dematol. 2002 Aug;47(2):231-240. PMID: 12140469
  10. Krowchuck DP. Treating acne: a practical guide. Med Clin North Am. 2000 Jul;84(4):811-828. PMID: 10928190
  11. Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dematol. 2009 May;60(5 Suppl):S1-S50. doi: 10.1016/j.jaad.2009.01.019. PMID: 19376456
  12. Thiboutot D. New treatments and therapeutic strategies for acne. Arch Fam Med. 2000 Feb;9(2):179-187. PMID: 10693736
  13. Strauss JS, Krowchuk DP, Leyden JJ, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007 Apr;56(4):651-663. PMID: 17276540
  14. Sinclair W, Jordaan HF. Acne guideline 2005 update. S Afr Med J. 2005 Nov;95:881-892. PMID: 16344888
  15. Titus S, Hodge J. Diagnosis and treatment of acne. Am Fam Physician. 2012 Oct;86(8):734-740. Accessed 29 Jul 2013. PMID: 23062156
  16. Usatine RP, Quan MA. Pearls in the management of acne: an advanced approach. Prim Care. 2000 Jun;27(2):289-308. PMID: 10815044
  17. Webster GF. Acne vulgaris. BMJ. 2002 Aug;325(7362):475-479. PMID: 12202330
  18. Yan AC. Current concepts in acne management. Adolesc Med Clin. 2006 Oct;17(3):613-637. PMID: 17030282
  19. Gilbert DN, Moellering RC, Eliopoulos GM, et al. The Sanford guide to antimicrobial therapy. 40th. Sperryville, VA: Antimicrobial Therapy Inc; 2010.
  20. Gilbert DN, Moellering RC, Eliopoulos GM, et al. The Sanford guide to antimicrobial therapy. 37th ed. Sperryville, VA: Antimicrobial Therapy Inc; 2007
  21. Habif TP. Acne, Rosacea, and Related Disorders. Clinical dermatology: A color guide to diagnosis and therapy. 4th ed. Pennsylvania: Mosby, Elsevier; 2004
  22. MedWorm
  23. Graber E. Treatment of acne vulgaris. UpToDate. 21 Oct 2019. Accessed 29 Jul 2013.
  24. Gutiérrez RM, Mitchell S, Solis RV. Psidium guajava: a review of its traditional uses, phytochemistry and pharmacology. J Ethnopharmacol. 2008 Apr 17;117(1):1-27. PMID: 18353572
  25. Goh CL, Noppakun N, Micali G, et al. Meeting the challenges of acne treatment in Asian patients: a review of the role of dermocosmetics as adjunctive therapy. J Cutan Aesthet Surg. 2016 Apr-Jun;9(2):85–92. doi: 10.4103/0974-2077.184043. PMID: 27398008
  26. Asai Y, Baibergenova A, Dutil M, et al. Management of acne: Canadian clinical practice guideline. CMAJ. 2016 Feb;188(2):118-126. doi: 10.1503/cmaj.140665. PMID: 26573753
  27. Eichenfield LF, Krakowski AC, Piggott C, et al; American Acne and Rosacea Society. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics. 2013 May;131(Suppl 3):S163-186. doi: 10.1542/peds.2013-0490B. PMID: 23637225
  28. Nast A, Dréno B, Bettoli V, et al. European evidence-based (S3) guideline for the treatment of acne - update 2016 - short version. J Eur Acad Dermatol Venereol. 2016 Aug;30(8):1261-1268. doi: 10.1111/jdv.13776. PMID: 27514932
  29. Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016 May;74(5):945-973.e33. doi: 10.1016/j.jaad.2015.12.037. PMID: 26897386
  30. Dover JS, Batra P. Light-based, adjunctive, and other therapies for acne vulgaris. UpToDate. 26 Sep 2019.
  31. Graber E. Hormonal therapy for women with acne vulgaris. UpToDate. 26 Sep 2019.
  32. Oon HH, Wong SN, Aw DCW, et al. Acne management guidelines by the Dermatological Society of Singapore. J Clin Aesthet Dermatol. 2019 Jul;12(7):34-50. PMID: 31531161
  33. Thiboutot DM, Dréno B, Abanmi A, et al. Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2018 Feb;78(2)(Suppl 1):S1-S23.e1. doi: 10.1016/j.jaad.2017.09.078. PMID: 29127053
  34. Thiboutot D, Zaenglein A. Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris. UpToDate. 8 Oct 2019.
Editor's Recommendations
Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.